NCLT initiates insolvency proceedings against Orchid Pharma
Firm exploring options to appeal against the order following consultations with legal counsel
)
Explore Business Standard
Associate Sponsors
Co-sponsor
Firm exploring options to appeal against the order following consultations with legal counsel
)
The company, in a regulatory filing, said that the order issued by the Chennai bench, admitting the petition filed by an operational creditor Lakshmi Vilas Bank Ltd, initiates corporate insolvency resolution process (CIRP) against the pharmaceutical firm.
The company is in the process of exploring a suitable legal recourse, including preferring an appeal before the NCLT following consultations with its legal counsel.
Orchid Pharma, once a leader in injectables and some of the Active Pharmaceutical Ingredients (API) manufacturing, has been suffering from a financial crisis for a number of years now and its investors and lenders have approached various legal forums in their lookout for a remedy.
Already subscribed? Log in
Subscribe to read the full story →
3 Months
₹300/Month
1 Year
₹225/Month
2 Years
₹162/Month
Renews automatically, cancel anytime
Over 30 premium stories daily, handpicked by our editors


News, Games, Cooking, Audio, Wirecutter & The Athletic
Digital replica of our daily newspaper — with options to read, save, and share


Insights on markets, finance, politics, tech, and more delivered to your inbox
In-depth market analysis & insights with access to The Smart Investor


Repository of articles and publications dating back to 1997
Uninterrupted reading experience with no advertisements


Access Business Standard across devices — mobile, tablet, or PC, via web or app
First Published: Aug 23 2017 | 7:42 PM IST